The Alzheimer’s Association and the Paul G. Allen Family Foundation recently announced the award of three grants to assess the role of the immune system in Alzheimer’s disease. The awards represent an investment of $500,000 to advance this understudied yet immense area of scientific knowledge, which could play a major role…
News
Alzheimer’s Association to Fund Music and Memory Program at Brandywine Senior Living South Jersey
Brandywine Senior Living, a leading provider of quality care and services to seniors, has just partnered with the Alzheimer’s Association Delaware Valley Chapter to remind its residents living with this neurodegenerative disease of the joy of listening to music. Thanks to generous funding from the Association, residents will soon rediscover the…
Piramal Imaging recently announced that it will present nine studies on the effects of Neuraceq (florbetaben F18 injection) at the Alzheimer’s Association International Annual Conference (AAIC), July 18-23, 2015 at the Walter E. Washington Convention Center in Washington, D.C. Neuraceq is indicated for Positron Emission Tomography (PET) imaging of…
With recent developments in stem cell research opening up the enormous potential for advancing the field of regenerative medicine, researchers are exploring ways that stem cell therapeutics may prove able to treat and possibly even reverse effects of debilitating diseases such as Alzheimer’s, type 1 diabetes and muscular dystrophy. Professionals…
Researchers at Cedars-Sinai Medical Center recently published in the journal Brain a new promising immune therapeutic strategy for Alzheimer’s disease using mice models. The study is entitled “Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer’s disease”.
Researchers from Columbia University Medical Center (CUMC) have released multiple study findings showing that long term memories are stored with the help of prion-like proteins called CPEB. These CPEB proteins work to form long term memory in the same way as the mechanisms that cause mad cow disease, kuru, and other…
Alzheimer’s disease is responsible for up to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts with difficulty remembering recent events. It is often a patient’s family member that notices this loss of function and that urges the patient to see the doctor. Presently, there…
In a new study entitled “Novel DNA repair mechanism brings new horizons: Researchers discover new mechanism of DNA repair, which will help to treat and to prevent diseases in the future” researchers discovered a new mechanism on how the DNA molecule repairs itself which may translate into…
In a recent study published in the journal Computational and Mathematical Methods in Medicine, a team of researchers found that the use of multiscale entropy analysis (MSE), of EEG signals, especially Slope 2, provides a potential tool for predicting the efficacy of AChE inhibitors prior to…
A recent study titled, “ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment,” reported in this month’s issue of The FASEB Journal, is backing all the hype surrounding fish oil and antioxidant supplements as a potential means to…
Recent Posts
- FDA decision on AXS-05 for Alzheimer’s agitation expected April 30 January 6, 2026
- Oral semaglutide fails to slow Alzheimer’s in pair of clinical trials December 2, 2025
- Canada gives conditional OK to early Alzheimer’s drug Leqembi November 4, 2025
- Kisunla approval offers new option to treat early Alzheimer’s in Europe October 3, 2025
- Guest Voice: A journey through loss, love, and remembrance October 2, 2025